Cheng, Ning
Rahman, Md. Motiur
Alatawi, Yasser
Qian, Jingjing
Peissig, Peggy L.
Berg, Richard L.
Page, C. David
Hansen, Richard A.
Funding for this research was provided by:
U.S. Food and Drug Administration (U01FD005272, HHSF2232015101102C)
National Institutes of Health (2R01GM097618-04)
Article History
First Online: 2 December 2017
Compliance with Ethical Standards
:
: In the past 3 years, Richard A. Hansen has provided expert testimony for Daiichi Sankyo. Richard Hansen and Jingjing Qian also have received grant funding from US FDA Grant U01FD005272 and contract HHSF2232015101102C, and these grants are directly related to the general topic of this manuscript. Dr. Hansen also received funding from National Institute of Health grant 2R01GM097618-04, which is related to but did not directly fund this work. Ning Cheng, Md. Motiur Rahman, Yasser Alatawi, Jingjing Qian, Peggy L. Peissig, Richard L. Berg, and David Page have no conflicts of interest that are directly relevant to the content of this study. Views expressed in written materials or publications and by speakers do not necessarily reflect the official policies of the Department of Health and Human Services; nor does any mention of trade names, commercial practices, or organization imply endorsement by the United States Government.
: This study was supported by the U.S. Food and Drug Administration through Grant U01FD005272 and contract HHSF2232015101102C. A National Institute of Health Grant 2R01GM097618-04 provided related support but did not directly fund this study.
: The study was approved by the Auburn University Institutional Review Board for research involving human subjects (protocol 14-465 EP1410).